FI940072A - Pyrrolidiinijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet - Google Patents

Pyrrolidiinijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet Download PDF

Info

Publication number
FI940072A
FI940072A FI940072A FI940072A FI940072A FI 940072 A FI940072 A FI 940072A FI 940072 A FI940072 A FI 940072A FI 940072 A FI940072 A FI 940072A FI 940072 A FI940072 A FI 940072A
Authority
FI
Finland
Prior art keywords
preparation
pyrrolidine derivatives
medicines containing
medicines
pyrrolidine
Prior art date
Application number
FI940072A
Other languages
English (en)
Swedish (sv)
Other versions
FI105190B (fi
FI940072A0 (fi
Inventor
Marc Capet
Michel Cheve
Claude Cotrel
Marie-Christine Dubroeucq
Gilles Dutruc-Rosset
Claude Guyon
Michel Joannic
Franco Manfre
Gerard Roussel
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI940072A0 publication Critical patent/FI940072A0/fi
Publication of FI940072A publication Critical patent/FI940072A/fi
Application granted granted Critical
Publication of FI105190B publication Critical patent/FI105190B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
FI940072A 1991-07-10 1994-01-07 Menetelmä terapeuttisesti käyttökelpoisten pyrrolidiinijohdannaisten valmistamiseksi FI105190B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9108675A FR2678938B1 (fr) 1991-07-10 1991-07-10 Derives de pyrrolidine, leur preparation et les medicaments les contenant.
FR9108675 1991-07-10
FR9200626 1992-07-03
PCT/FR1992/000626 WO1993001167A1 (fr) 1991-07-10 1992-07-03 Derives de pyrrolidine et thiazolidine, leur preparation et les medicaments les contenant

Publications (3)

Publication Number Publication Date
FI940072A0 FI940072A0 (fi) 1994-01-07
FI940072A true FI940072A (fi) 1994-01-07
FI105190B FI105190B (fi) 2000-06-30

Family

ID=9414933

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940072A FI105190B (fi) 1991-07-10 1994-01-07 Menetelmä terapeuttisesti käyttökelpoisten pyrrolidiinijohdannaisten valmistamiseksi

Country Status (23)

Country Link
US (1) US5610144A (fi)
EP (2) EP0527069A1 (fi)
JP (1) JP3034043B2 (fi)
KR (1) KR100234927B1 (fi)
AT (1) ATE120732T1 (fi)
AU (1) AU662345B2 (fi)
BR (1) BR1100717A (fi)
CA (1) CA2102697C (fi)
CZ (1) CZ283602B6 (fi)
DE (1) DE69201956T2 (fi)
DK (1) DK0593639T3 (fi)
ES (1) ES2071510T3 (fi)
FI (1) FI105190B (fi)
FR (1) FR2678938B1 (fi)
HU (1) HU223470B1 (fi)
IE (1) IE66331B1 (fi)
NO (1) NO180166C (fi)
NZ (1) NZ243514A (fi)
PL (5) PL171095B1 (fi)
RU (1) RU2118316C1 (fi)
SK (1) SK1694A3 (fi)
WO (1) WO1993001167A1 (fi)
ZA (1) ZA925128B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2695641B1 (fr) * 1992-09-11 1994-11-25 Rhone Poulenc Rorer Sa (Amino-3 phényl)-1 éthanesulfonate d'hydroquinine optiquement actif, sa préparation et son utilisation.
FR2700167B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine et thiazolidine, leur préparation et les médicaments les contenant.
FR2700165B1 (fr) * 1993-01-07 1995-02-17 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
FR2700168B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Dérivés de thiazolidine, leur préparation et les médicaments les contenant.
FR2700166B1 (fr) * 1993-01-07 1995-02-17 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
US5744485A (en) * 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
FR2721314B1 (fr) * 1994-06-20 1996-07-19 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
FR2721608B1 (fr) * 1994-06-22 1996-07-19 Rhone Poulenc Rorer Sa Dérivés de thiazolidine, leur préparation et les médicaments les contenant.
FR2734724B1 (fr) * 1995-06-01 1997-07-04 Rhone Poulenc Rorer Sa Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'alcoolisme
SK72096A3 (en) 1995-06-06 1997-11-05 Pfizer Indole-2-carboxamides, glycogen phosphorylase inhibitors and pharmauceutical compositions
KR100241643B1 (ko) * 1995-06-06 2000-03-02 디. 제이. 우드 당뇨병치료제인 치환된 N-(인돌-2-카르보닐)-β-알라님아미드 및 그의 유도체
FR2744361B1 (fr) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
TW442449B (en) 1996-07-04 2001-06-23 Hoechst Ag Process for preparing 1,2-dichloroethane by direct chlorination
IT1300055B1 (it) * 1998-04-17 2000-04-05 Boehringer Ingelheim Italia Eterocicli con anello a 5 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmici
EP1296949A2 (en) * 2000-06-21 2003-04-02 Bristol-Myers Squibb Pharma Company Piperidine amides as modulators of chemokine receptor activity
US6277877B1 (en) * 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
PT1392291E (pt) * 2000-10-30 2007-08-24 Janssen Pharmaceutica Nv Inibidores da tripeptidil-peptidase
US7105556B2 (en) 2001-05-30 2006-09-12 Bristol-Myers Squibb Company Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
NZ538567A (en) * 2002-09-19 2007-04-27 Abbott Lab Pyrrolidine-2-carbonitrile derivatives and their pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
US7262207B2 (en) 2002-09-19 2007-08-28 Abbott Laboratories Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
US7238724B2 (en) 2002-09-19 2007-07-03 Abbott Laboratories Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
US6846836B2 (en) 2003-04-18 2005-01-25 Bristol-Myers Squibb Company N-substituted phenylurea inhibitors of mitochondrial F1F0 ATP hydrolase
US7230002B2 (en) 2004-02-03 2007-06-12 Glenmark Pharmaceuticals Ltd. Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof
EA200601471A1 (ru) * 2004-02-11 2007-10-26 Зи Охайо Стэйт Юнивесити Рисеч Фаундейшн Ингибиторы клеточной пролиферации клеток (варианты), фармацевтическая композиция на их основе, способ уничтожения раковых клеток (варианты) и способ лечения и профилактики злокачественных состояний (варианты)
WO2007086584A1 (ja) * 2006-01-30 2007-08-02 Meiji Seika Kaisha, Ltd. 新規ＦａｂＫおよびＦａｂＩ／Ｋ阻害剤
CN101516872A (zh) * 2006-07-20 2009-08-26 艾博特公司 (2s,5r)-5-乙炔基-1-{n-(4-甲基-1-(4-羧基-吡啶-2-基)哌啶-4-基)甘氨酰}吡咯烷-2-甲腈的合成
US8247438B2 (en) * 2008-02-27 2012-08-21 Neuropill, Inc. Methods for treating schizophrenia
CN101407502B (zh) * 2008-11-21 2010-12-22 南京大学 一类n-(叔丁氧基羰基)噻唑烷酸类化合物及其制法和用途
DE102009004204A1 (de) * 2009-01-09 2010-07-15 Christian-Albrechts-Universität Zu Kiel Verfahren zur verbesserten Bioaktivierung von Arzneistoffen
MX339252B (es) * 2009-12-18 2016-05-18 Euroscreen Sa Derivados de acido carboxilico de pirrolidina o tiazolidina, composicion farmaceutica y metodos para su uso en el tratamiento de transtornos metabolicos, como agonistas del receptor 43 acoplado por proteina-g (gpr43).
WO2012036962A2 (en) 2010-09-13 2012-03-22 Amylin Pharmaceuticals, Inc. C-terminal amidation of polypeptides
DK3074008T3 (da) 2013-11-27 2019-10-21 Epics Therapeutics Forbindelser, farmaceutisk sammensætning og fremgangsmåder til anvendelse i behandling af inflammation
WO2016118961A1 (en) 2015-01-24 2016-07-28 Academia Sinica Cancer markers and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH362072A (de) * 1957-03-19 1962-05-31 Ciba Geigy Verfahren zur Herstellung neuer Acylpiperidine
US4499102A (en) * 1979-12-13 1985-02-12 Santen Pharmaceutical Co., Ltd. Thiazolidine and pyrrolidine compounds and pharmaceutical compositions containing them
DE3272505D1 (en) * 1981-03-09 1986-09-18 Merck & Co Inc Substituted thiazolidine carboxylic acid analogs and derivatives as antihypertensives
DE3332633A1 (de) * 1983-09-09 1985-04-04 Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel
CA2022346A1 (en) * 1989-08-04 1991-02-05 Mitsubishi Chemical Corporation 1-phenylalkyl-3-phenylurea derivatives
US5258405A (en) * 1990-03-12 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Urea derivatives and salts thereof in method for inhibiting the ACAT enzyme

Also Published As

Publication number Publication date
NO180166B (no) 1996-11-18
CA2102697A1 (fr) 1993-01-11
FR2678938A1 (fr) 1993-01-15
PL171112B1 (pl) 1997-03-28
JPH06509331A (ja) 1994-10-20
IE66331B1 (en) 1995-12-27
AU662345B2 (en) 1995-08-31
CA2102697C (fr) 2003-09-30
NZ243514A (en) 1995-03-28
JP3034043B2 (ja) 2000-04-17
DE69201956T2 (de) 1995-11-30
EP0593639B1 (fr) 1995-04-05
WO1993001167A1 (fr) 1993-01-21
CZ283602B6 (cs) 1998-05-13
PL171054B1 (pl) 1997-02-28
ATE120732T1 (de) 1995-04-15
EP0593639A1 (fr) 1994-04-27
US5610144A (en) 1997-03-11
FR2678938B1 (fr) 1993-10-08
ES2071510T3 (es) 1995-06-16
DK0593639T3 (da) 1995-07-03
KR100234927B1 (ko) 2000-02-01
FI105190B (fi) 2000-06-30
AU2327592A (en) 1993-02-11
ZA925128B (en) 1993-04-28
HU223470B1 (hu) 2004-07-28
PL171094B1 (pl) 1997-03-28
RU2118316C1 (ru) 1998-08-27
NO180166C (no) 1997-02-26
PL171333B1 (pl) 1997-04-30
BR1100717A (pt) 2000-03-14
FI940072A0 (fi) 1994-01-07
IE922244A1 (en) 1993-01-13
PL171095B1 (pl) 1997-03-28
NO934300L (no) 1993-11-26
CZ4994A3 (en) 1994-04-13
SK1694A3 (en) 1994-12-07
DE69201956D1 (de) 1995-05-11
HU9400061D0 (en) 1994-05-30
HUT70403A (en) 1995-10-30
NO934300D0 (no) 1993-11-26
EP0527069A1 (fr) 1993-02-10

Similar Documents

Publication Publication Date Title
FI940072A0 (fi) Pyrrolidiinijohdannaiset, niiden valmistus ja niitä sisältävät lääkkeet
NO921835L (no) Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav
ATE170510T1 (de) 3-(hydroxybenzylidenyl)-indolin-2-one und diese enthaltende arzneimittel
NZ244021A (en) Benzylthiazolidinedione derivatives, preparation and pharmaceutical compositions thereof
NO171365C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
ATE122033T1 (de) Cyancrotonsäureamidverbindung als arzneimittel mit immunmodulierenden eigenschaften.
ES2074846T3 (es) Nuevas naftil-etil-ureas y naftil-etil-tioureas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
EP0382077A3 (de) Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus
ES2091310T3 (es) Nuevos derivados de la n-benzoil-prolina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
NO930029D0 (no) 4,13-dioxabicyklo(8.2.1)tridecenonderivater, fremgangsmaater og mellomprodukter for deres fremstilling, og legemidler inneholdene disse forbindelser
ES2111871T3 (es) Nuevos derivados de aminoacidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
EP0533516A3 (fr) Nouveaux composés amidiques des 1-(alcoxybenzyl) pipérazines, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent
EP0535250A4 (en) Novel compounds and use thereof as medicine
YU44392A (sh) Postupak za dobijanje farmaceutske formulacije diritromicina
DE3853958D1 (de) Substituierte Pyridin-Verbindungen, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
DK284588A (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
NO903291L (no) Renin-hemmende aminooligohydroksyderivater.
DK0418990T3 (da) 13-brom- og 13,14-dibrom-ergoliner, deres fremstilling og anvendelse i lægemidler
DK0631777T3 (da) Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning
GR3015592T3 (en) Pharmaceuticals containing substituted cyclohex-2-en-1-yl-amine derivatives and their use in combatting diseases.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: AVENTIS PHARMA S.A.

MA Patent expired